drugset
drugset / Trial / NCT07305675

Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment of Atrophic Acne Scars.

NCT07305675 ↗

Completed 30 enrolled Second Affiliated Hospital of Xi'an Jiaotong University
RandomizedParallel-groupSingle-blindTreatment

Summary

Atrophic acne scars (AAS) is one of the most common skin sequelae following acne vulgaris. Fractional laser has shown great therapeutic potential in recent years, while there is no standard of wound care after laser resurfacing. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a multifunctional cytokine, and has shown its value in many other acute wounds healing. In the present study, we investigated the efficacy and safety of topical recombinant human GM-CSF combined with 1927-nm fractional thulium fiber laser (TFL) in AAS treatment.

Timeline

Start
2025-01-01
Primary completion
2025-09-01
Completion
2025-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject rhGM-CSF Protein / enzyme biologic 100 unknown Topical

Indications

No indication recorded.